Natixis Inari Medical, Inc. Transaction History

Natixis

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$48.3 - $68.06 $109,689 - $154,564	-2,271 Reduced 19.2%	9,559 $620,000
Q3 2023 Nov 14, 2023	SELL	$54.2 - $71.67 $101,896 - $134,739	-1,880 Reduced 13.71%	11,830 $773,000
Q2 2023 Aug 11, 2023	SELL	$56.23 - $71.17 $4,385 - $5,551	-78 Reduced 0.57%	13,710 $797,000
Q1 2023 May 12, 2023	BUY	$53.43 - $68.12 $736,692 - $939,238	13,788 New	13,788 $851,000
Q4 2022 Feb 13, 2023	BUY	$61.23 - $83.62 $869,404 - $1.19 Million	14,199 New	14,199 $902,000

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.77B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.